Press Release
Protein LITAF Provides Resistance to Pore-Forming Toxin-Induced Cell Death
Read More
External News
Science in Seattle: A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab
Read the publication ➡
Press Release
Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award
Read More
News
BRI Investigator Alice Long, PhD, Interviewed on the Immunology Podcast
Read More
Press Release
Benaroya Research Institute Immunologist John Ray Receives 2023 NIH Director’s New Innovator Award
Read More
Press Release
Benaroya Research Institute Receives $9 Million in Funding, With a Focus on Down Syndrome Research
Read More
News
BRI Investigators Jane Buckner, MD, and Carmen Mikacenic, MD, Interviewed on the Arthritis Life Podcast
Read More
External News
Researchers zoom in on new ways to view biomolecules in pathogens
Read More ➡
Press Release
Benaroya Research Institute Awarded $3.1 Million National Institutes of Health Grant to Study the Inflammatory Cycle of Common Skin Diseases
Read More
News
Vlad V. Simianu, MD, MPH, Appointed as Medical Director of Benaroya Research Institute’s Clinical Research Program
Read More
External News
Invent@SC’s Future Biotech Leaders, a post-doctoral training program developed in partnership with BRI, FHCRC and UW
Read more ➡
External News
Former Seahawk Jordan Babineaux talks about the upcoming Boeing Classic, a golf tournament benefiting BRI
Watch the video ➡
External News
Monitoring T cells may allow prevention of type 1 diabetes
Read More ➡
External News
Comment: As Asthma Incidence Rises, Tailor Treatments Better
Read More ➡
Press Release
